Cargando…

NAFLD Preclinical Models: More than a Handful, Less of a Concern?

Non-alcoholic fatty liver disease (NAFLD) is a spectrum of liver diseases ranging from simple steatosis to non-alcoholic steatohepatitis, fibrosis, cirrhosis, and/or hepatocellular carcinoma. Due to its increasing prevalence, NAFLD is currently a major public health concern. Although a wide variety...

Descripción completa

Detalles Bibliográficos
Autores principales: Oligschlaeger, Yvonne, Shiri-Sverdlov, Ronit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167756/
https://www.ncbi.nlm.nih.gov/pubmed/32046285
http://dx.doi.org/10.3390/biomedicines8020028
_version_ 1783523598114226176
author Oligschlaeger, Yvonne
Shiri-Sverdlov, Ronit
author_facet Oligschlaeger, Yvonne
Shiri-Sverdlov, Ronit
author_sort Oligschlaeger, Yvonne
collection PubMed
description Non-alcoholic fatty liver disease (NAFLD) is a spectrum of liver diseases ranging from simple steatosis to non-alcoholic steatohepatitis, fibrosis, cirrhosis, and/or hepatocellular carcinoma. Due to its increasing prevalence, NAFLD is currently a major public health concern. Although a wide variety of preclinical models have contributed to better understanding the pathophysiology of NAFLD, it is not always obvious which model is best suitable for addressing a specific research question. This review provides insights into currently existing models, mainly focusing on murine models, which is of great importance to aid in the identification of novel therapeutic options for human NAFLD.
format Online
Article
Text
id pubmed-7167756
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-71677562020-04-21 NAFLD Preclinical Models: More than a Handful, Less of a Concern? Oligschlaeger, Yvonne Shiri-Sverdlov, Ronit Biomedicines Review Non-alcoholic fatty liver disease (NAFLD) is a spectrum of liver diseases ranging from simple steatosis to non-alcoholic steatohepatitis, fibrosis, cirrhosis, and/or hepatocellular carcinoma. Due to its increasing prevalence, NAFLD is currently a major public health concern. Although a wide variety of preclinical models have contributed to better understanding the pathophysiology of NAFLD, it is not always obvious which model is best suitable for addressing a specific research question. This review provides insights into currently existing models, mainly focusing on murine models, which is of great importance to aid in the identification of novel therapeutic options for human NAFLD. MDPI 2020-02-08 /pmc/articles/PMC7167756/ /pubmed/32046285 http://dx.doi.org/10.3390/biomedicines8020028 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Oligschlaeger, Yvonne
Shiri-Sverdlov, Ronit
NAFLD Preclinical Models: More than a Handful, Less of a Concern?
title NAFLD Preclinical Models: More than a Handful, Less of a Concern?
title_full NAFLD Preclinical Models: More than a Handful, Less of a Concern?
title_fullStr NAFLD Preclinical Models: More than a Handful, Less of a Concern?
title_full_unstemmed NAFLD Preclinical Models: More than a Handful, Less of a Concern?
title_short NAFLD Preclinical Models: More than a Handful, Less of a Concern?
title_sort nafld preclinical models: more than a handful, less of a concern?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167756/
https://www.ncbi.nlm.nih.gov/pubmed/32046285
http://dx.doi.org/10.3390/biomedicines8020028
work_keys_str_mv AT oligschlaegeryvonne nafldpreclinicalmodelsmorethanahandfullessofaconcern
AT shirisverdlovronit nafldpreclinicalmodelsmorethanahandfullessofaconcern